All Information (Except Text) for S.3742 - Cancer Drug Parity Act of 2018115th Congress (2017-2018)
|Sponsor:||Sen. Smith, Tina [D-MN] (Introduced 12/12/2018)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 12/12/2018 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Short Titles - Senate
Short Titles as Introduced
Cancer Drug Parity Act of 2018
Official Titles - Senate
Official Titles as Introduced
A bill to amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.
Actions Overview (1)
|12/12/2018||Introduced in Senate|
12/12/2018 Introduced in Senate
All Actions (1)
|12/12/2018||Read twice and referred to the Committee on Health, Education, Labor, and Pensions.|
Action By: Senate
12/12/2018 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|Sen. Moran, Jerry [R-KS]*||12/12/2018|
|Sen. Murphy, Christopher [D-CT]*||12/12/2018|
|Sen. Wicker, Roger F. [R-MS]*||12/12/2018|
|Sen. Baldwin, Tammy [D-WI]||12/20/2018|
|Sen. Whitehouse, Sheldon [D-RI]||12/20/2018|
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Health, Education, Labor, and Pensions||12/12/2018||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (1)
Introduced in Senate (12/12/2018)
Cancer Drug Coverage Act of 2018
This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.